Bioprinting technologies are being explored for their potential to enhance prenatal and neonatal care, including the development of placenta models to study and treat conditions such as preeclampsia. Additionally, bioprinted tissues could provide new treatments for congenital defects and conditions diagnosed in utero, offering hope for interventions that could improve health outcomes for both mothers and their newborns.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.